The University of Chicago Header Logo

Connection

Valluvan Jeevanandam to Heart-Assist Devices

Back to Details
This is a "connection" page, showing publications Valluvan Jeevanandam has written about Heart-Assist Devices.
Valluvan Jeevanandam
Connection Strength
14.884
Heart-Assist Devices
  1. Does PTFE coverage facilitate LVAD explant and heart transplant? J Card Surg. 2022 12; 37(12):4324.
    View in: PubMed
    Score: 0.428
  2. Anemia and outcomes following left ventricular assist device implantation. Artif Organs. 2022 Aug; 46(8):1626-1635.
    View in: PubMed
    Score: 0.412
  3. Impact of Aspirin Dosing on Thrombotic Outcomes in Patients with the HVAD. ASAIO J. 2021 09 01; 67(9):e153-e156.
    View in: PubMed
    Score: 0.398
  4. Does outflow graft placement during LVAD implantation affect outcomes? J Card Surg. 2021 Nov; 36(11):4102.
    View in: PubMed
    Score: 0.395
  5. STS INTERMACS Database: The Key to Conduct Single-Arm Trials in Advanced Heart Failure Patients. Ann Thorac Surg. 2022 03; 113(3):808-815.
    View in: PubMed
    Score: 0.389
  6. A model for continued LVAD patient success: A 4-year readmission-free HeartMate 3 postoperative course. J Card Surg. 2021 Mar; 36(3):1159-1161.
    View in: PubMed
    Score: 0.382
  7. Impact of plasma volume status on mortality following left ventricular assist device implantation. Artif Organs. 2021 Jun; 45(6):587-592.
    View in: PubMed
    Score: 0.380
  8. An International Study on Ventricular Assist Device Program Models. Prog Transplant. 2020 12; 30(4):355-359.
    View in: PubMed
    Score: 0.373
  9. Perioperative improvement in serum albumin level in patients with left ventricular assist device. J Card Surg. 2020 Nov; 35(11):3070-3077.
    View in: PubMed
    Score: 0.372
  10. Winter LVAD implantation is associated with adverse clinical outcomes. Int J Artif Organs. 2021 Mar; 44(3):188-193.
    View in: PubMed
    Score: 0.372
  11. Sex difference in the impact of smoking on left ventricular assist device outcomes. J Card Surg. 2020 Nov; 35(11):2913-2919.
    View in: PubMed
    Score: 0.369
  12. Opioid Use and Morbidities during Left Ventricular Assist Device Support. Int Heart J. 2020 May 30; 61(3):547-552.
    View in: PubMed
    Score: 0.363
  13. Effect of tobacco smoking on outcomes after left ventricular assist device implantation. Artif Organs. 2020 Jul; 44(7):693-699.
    View in: PubMed
    Score: 0.358
  14. The first-in-human experience with a minimally invasive, ambulatory, counterpulsation heart assist system for advanced congestive heart failure. J Heart Lung Transplant. 2018 01; 37(1):1-6.
    View in: PubMed
    Score: 0.306
  15. Atrial Arrhythmias and Electroanatomical Remodeling in Patients With Left Ventricular Assist Devices. J Am Heart Assoc. 2017 Mar 08; 6(3).
    View in: PubMed
    Score: 0.292
  16. Invasive Hemodynamic Echocardiographic Ramp Test in the HeartAssist5 LVAD: Insights into Device Performance. ASAIO J. 2017 Mar/Apr; 63(2):e10-e12.
    View in: PubMed
    Score: 0.291
  17. Yes, minimally invasive left ventricular device implantation can be done-but should it? J Thorac Cardiovasc Surg. 2016 11; 152(5):1448-1449.
    View in: PubMed
    Score: 0.280
  18. Durability of De Vega tricuspid valve annuloplasty for severe tricuspid regurgitation during left ventricular assist device implantation. Ann Thorac Surg. 2014 Jul; 98(1):81-3.
    View in: PubMed
    Score: 0.240
  19. Transapical approach for mitral valve repair during insertion of a left ventricular assist device. ScientificWorldJournal. 2013; 2013:925310.
    View in: PubMed
    Score: 0.226
  20. Are we ready to implant left ventricular assist devices in "less sick" patients? Semin Thorac Cardiovasc Surg. 2012; 24(1):8-10.
    View in: PubMed
    Score: 0.204
  21. Reversal of impaired myocardial beta-adrenergic receptor signaling by continuous-flow left ventricular assist device support. J Heart Lung Transplant. 2010 Jun; 29(6):603-9.
    View in: PubMed
    Score: 0.179
  22. Technique for left ventricular apical cannulation for short-term mechanical circulatory support. Ann Thorac Surg. 2010 Mar; 89(3):994-5.
    View in: PubMed
    Score: 0.179
  23. The evolution of cardiac assist device technology. J Heart Lung Transplant. 2010 Jan; 29(1):11-2.
    View in: PubMed
    Score: 0.174
  24. Mitigating Post-operative Right Ventricular Dysfunction After Left Ventricular Assist Device: The RV Protection Study. J Card Fail. 2026 Jan; 32(1):46-57.
    View in: PubMed
    Score: 0.126
  25. Early and Late Outcomes of Ambulatory Counter Pulsation Devices as a Bridge to Heart Transplantation. Cardiology. 2025; 150(4):381-388.
    View in: PubMed
    Score: 0.125
  26. The quest for permanent ventricular assistance: the role of aortic counterpulsation. ASAIO J. 2004 Nov-Dec; 50(6):xxxvii-xlii.
    View in: PubMed
    Score: 0.124
  27. Quality of Anticoagulation With Phenprocoumon and Warfarin in Left Ventricular Assist Device Patients: A Multicenter Study. ASAIO J. 2023 06 01; 69(6):595-601.
    View in: PubMed
    Score: 0.110
  28. The prognostic role of advanced hemodynamic variables in patients with left ventricular assist devices. Artif Organs. 2023 Mar; 47(3):574-581.
    View in: PubMed
    Score: 0.108
  29. Circulatory assistance with a permanent implantable IABP: initial human experience. Circulation. 2002 Sep 24; 106(12 Suppl 1):I183-8.
    View in: PubMed
    Score: 0.107
  30. Clinical outcomes of grafted vs. percutaneous axillary intra-aortic balloon pump support as a bridge to transplantation: a propensity score-matched analysis. Heart Vessels. 2022 Dec; 37(12):1995-2001.
    View in: PubMed
    Score: 0.106
  31. Surgical Correction of Spontaneous Outflow Graft Twisting of HeartMate 3 LVAD via a Subcostal Approach. Heart Surg Forum. 2022 Feb 28; 25(1):E152-E154.
    View in: PubMed
    Score: 0.103
  32. Significant vascular complications in percutaneous axillary intra-aortic balloon pump. Ann Vasc Surg. 2022 Jul; 83:42-52.
    View in: PubMed
    Score: 0.102
  33. Implications of Heart Rate in Patients with Left Ventricular Assist Devices. Int Heart J. 2022; 63(1):56-61.
    View in: PubMed
    Score: 0.102
  34. Ten-year, single center experience of ambulatory axillary intra-aortic balloon pump support for heart failure. J Cardiol. 2022 05; 79(5):611-617.
    View in: PubMed
    Score: 0.101
  35. Proximal ascending aorta size is associated with the incidence of de novo aortic insufficiency with left ventricular assist device. Heart Vessels. 2022 Apr; 37(4):647-653.
    View in: PubMed
    Score: 0.100
  36. Short-Term Ventricular Structural Changes Following Left Ventricular Assist Device Implantation. ASAIO J. 2021 02 01; 67(2):169-176.
    View in: PubMed
    Score: 0.096
  37. Increased Rate of Pump Thrombosis and Cardioembolic Events Following Ventricular Tachycardia Ablation in Patients Supported With Left Ventricular Assist Devices. ASAIO J. 2020 Nov/Dec; 66(10):1127-1136.
    View in: PubMed
    Score: 0.094
  38. Impact of worsening of aortic insufficiency during HeartMate 3 LVAD support. Artif Organs. 2021 Mar; 45(3):297-302.
    View in: PubMed
    Score: 0.094
  39. An international survey: Tobacco smoking cessation strategies within left ventricular assist device centers. Int J Artif Organs. 2021 Feb; 44(2):110-114.
    View in: PubMed
    Score: 0.092
  40. Neurohormonal Blockade During Left Ventricular Assist Device Support. ASAIO J. 2020 08; 66(8):881-885.
    View in: PubMed
    Score: 0.092
  41. Optimal cannula positioning of HeartMate 3 left ventricular assist device. Artif Organs. 2020 Dec; 44(12):e509-e519.
    View in: PubMed
    Score: 0.092
  42. Aortic Insufficiency During HeartMate 3 Left Ventricular Assist Device Support. J Card Fail. 2020 Oct; 26(10):863-869.
    View in: PubMed
    Score: 0.091
  43. Clinical Outcomes and Quality of Life With an Ambulatory Counterpulsation Pump in Advanced Heart Failure Patients: Results of the Multicenter Feasibility Trial. Circ Heart Fail. 2020 04; 13(4):e006666.
    View in: PubMed
    Score: 0.090
  44. Hemodynamic Effects of Concomitant Mitral Valve Surgery and Left Ventricular Assist Device Implantation. ASAIO J. 2020 04; 66(4):355-361.
    View in: PubMed
    Score: 0.090
  45. Decoupling Between Diastolic Pulmonary Artery and Pulmonary Capillary Wedge Pressures Is Associated With Right Ventricular Dysfunction and Hemocompatibility-Related Adverse Events in Patients With Left Ventricular Assist Devices. J Am Heart Assoc. 2020 04 07; 9(7):e014801.
    View in: PubMed
    Score: 0.090
  46. Short-Term Efficacy and Safety of Tolvaptan in Patients with Left Ventricular Assist Devices. ASAIO J. 2020 03; 66(3):253-257.
    View in: PubMed
    Score: 0.090
  47. Effect of Concomitant Tricuspid Valve Surgery With Left Ventricular Assist Device Implantation. Ann Thorac Surg. 2020 09; 110(3):918-924.
    View in: PubMed
    Score: 0.089
  48. HeartWare Ventricular Assist Device Cannula Position and Hemocompatibility-Related Adverse Events. Ann Thorac Surg. 2020 09; 110(3):911-917.
    View in: PubMed
    Score: 0.089
  49. Longitudinal Trajectories of Hemodynamics Following Left Ventricular Assist Device Implantation. J Card Fail. 2020 May; 26(5):383-390.
    View in: PubMed
    Score: 0.089
  50. HVAD Flow Waveform Estimates Left Ventricular Filling Pressure. J Card Fail. 2020 Apr; 26(4):342-348.
    View in: PubMed
    Score: 0.089
  51. Outcomes following left ventricular assist device exchange. J Card Surg. 2020 Mar; 35(3):591-597.
    View in: PubMed
    Score: 0.089
  52. Deep Y-Descent in Right Atrial Waveforms Following Left Ventricular Assist Device Implantation. J Card Fail. 2020 Apr; 26(4):360-367.
    View in: PubMed
    Score: 0.089
  53. Estimation of Central Venous Pressure by Pacemaker Lead Impedances in Left Ventricular Assist Device Patients. ASAIO J. 2020 01; 66(1):49-54.
    View in: PubMed
    Score: 0.089
  54. Combined Left Ventricular Assist Device and Coronary Artery Bypass Grafting Surgery: Should We Bypass the Bypass? ASAIO J. 2020 01; 66(1):32-37.
    View in: PubMed
    Score: 0.089
  55. Omega-3 and hemocompatibility-related adverse events. J Card Surg. 2020 Feb; 35(2):405-412.
    View in: PubMed
    Score: 0.088
  56. Surgical device exchange provides improved clinical outcomes compared to medical therapy in treating continuous-flow left ventricular assist device thrombosis. Artif Organs. 2020 Apr; 44(4):367-374.
    View in: PubMed
    Score: 0.088
  57. Estimation of the Severity of Aortic Insufficiency by HVAD Flow Waveform. Ann Thorac Surg. 2020 03; 109(3):945-949.
    View in: PubMed
    Score: 0.088
  58. Metabolic Dysfunction in Continuous-Flow Left Ventricular Assist Devices Patients and Outcomes. J Am Heart Assoc. 2019 11 19; 8(22):e013278.
    View in: PubMed
    Score: 0.088
  59. Hemodynamics of concomitant tricuspid valve procedures at LVAD implantation. J Card Surg. 2019 Dec; 34(12):1511-1518.
    View in: PubMed
    Score: 0.088
  60. Aortic Insufficiency and Hemocompatibility-related Adverse Events in Patients with Left Ventricular Assist Devices. J Card Fail. 2019 Oct; 25(10):787-794.
    View in: PubMed
    Score: 0.086
  61. Novel Formula to Calculate Three-Dimensional Angle Between Inflow Cannula and Device Body of HeartMate II LVAD. Ann Thorac Surg. 2020 01; 109(1):63-68.
    View in: PubMed
    Score: 0.086
  62. Association of Inflow Cannula Position with Left Ventricular Unloading and Clinical Outcomes in Patients with HeartMate II Left Ventricular Assist Device. ASAIO J. 2019 May/Jun; 65(4):331-335.
    View in: PubMed
    Score: 0.085
  63. A subcostal approach is favorable compared to sternotomy for left ventricular assist device exchange field of research: artificial heart (clinical). J Artif Organs. 2019 Sep; 22(3):181-187.
    View in: PubMed
    Score: 0.084
  64. A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report. N Engl J Med. 2019 04 25; 380(17):1618-1627.
    View in: PubMed
    Score: 0.084
  65. Outflow Cannula Systolic Slope in Patients With Left Ventricular Assist Devices: A Novel Marker of Myocardial Contractility. ASAIO J. 2019 02; 65(2):160-166.
    View in: PubMed
    Score: 0.083
  66. Optimal Hemodynamics During Left Ventricular Assist Device Support Are Associated With Reduced Readmission Rates. Circ Heart Fail. 2019 02; 12(2):e005094.
    View in: PubMed
    Score: 0.083
  67. Home Inotropes in Patients Supported with Left Ventricular Assist Devices. ASAIO J. 2019 01; 65(1):e7-e11.
    View in: PubMed
    Score: 0.083
  68. Optimal haemodynamics during left ventricular assist device support are associated with reduced haemocompatibility-related adverse events. Eur J Heart Fail. 2019 05; 21(5):655-662.
    View in: PubMed
    Score: 0.083
  69. Feasibility and utility of intraoperative epicardial scar characterization during left ventricular assist device implantation. J Cardiovasc Electrophysiol. 2019 02; 30(2):183-192.
    View in: PubMed
    Score: 0.083
  70. Improvement in Biventricular Cardiac Function After Ambulatory Counterpulsation. J Card Fail. 2019 Jan; 25(1):20-26.
    View in: PubMed
    Score: 0.082
  71. Repeated Ramp Tests on Stable LVAD Patients Reveal Patient-Specific Hemodynamic Fingerprint. ASAIO J. 2018 Nov/Dec; 64(6):701-707.
    View in: PubMed
    Score: 0.082
  72. Laparoscopic procedures in patients with cardiac ventricular assist devices. Surg Endosc. 2019 07; 33(7):2181-2186.
    View in: PubMed
    Score: 0.082
  73. Left Atrial Appendage Occlusion With Left Ventricular Assist Device Decreases Thromboembolic Events. Ann Thorac Surg. 2019 04; 107(4):1181-1186.
    View in: PubMed
    Score: 0.082
  74. Omega-3 Therapy Is Associated With Reduced Gastrointestinal Bleeding in Patients With Continuous-Flow Left Ventricular Assist Device. Circ Heart Fail. 2018 10; 11(10):e005082.
    View in: PubMed
    Score: 0.081
  75. Incidence and Outcomes of Postoperative Atrial Fibrillation After Left Ventricular Assist Device. ASAIO J. 2018 Sep/Oct; 64(5):581-585.
    View in: PubMed
    Score: 0.081
  76. Impact of Residual Valve Disease on Survival After Implantation of Left Ventricular Assist Devices. Ann Thorac Surg. 2018 12; 106(6):1789-1796.
    View in: PubMed
    Score: 0.081
  77. Decoupling Between Diastolic Pulmonary Arterial Pressure and Pulmonary Arterial Wedge Pressure at Incremental Left Ventricular Assist Device (LVAD) Speeds Is Associated With Worse Prognosis After LVAD Implantation. J Card Fail. 2018 Sep; 24(9):575-582.
    View in: PubMed
    Score: 0.080
  78. Residual native left ventricular function optimization using quantitative 3D echocardiographic assessment of rotational mechanics in patients with left ventricular assist devices. Echocardiography. 2018 10; 35(10):1606-1615.
    View in: PubMed
    Score: 0.080
  79. Echocardiographic Predictors of Hemodynamics in Patients Supported With Left Ventricular Assist Devices. J Card Fail. 2018 Sep; 24(9):561-567.
    View in: PubMed
    Score: 0.080
  80. HVAD: The ENDURANCE Supplemental Trial. JACC Heart Fail. 2018 09; 6(9):792-802.
    View in: PubMed
    Score: 0.080
  81. Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure. N Engl J Med. 2018 Apr 12; 378(15):1386-1395.
    View in: PubMed
    Score: 0.078
  82. Increased Risk of Bleeding in Left Ventricular Assist Device Patients Treated with Enoxaparin as Bridge to Therapeutic International Normalized Ratio. ASAIO J. 2018 Mar/Apr; 64(2):140-146.
    View in: PubMed
    Score: 0.078
  83. Preoperative Right-Sided Cardiac Congestion Is Associated with Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices. Dig Dis Sci. 2018 Jun; 63(6):1518-1524.
    View in: PubMed
    Score: 0.078
  84. Long-Acting Octreotide Reduces the Recurrence of Gastrointestinal Bleeding in Patients With a Continuous-Flow Left Ventricular Assist Device. J Card Fail. 2018 Apr; 24(4):249-254.
    View in: PubMed
    Score: 0.078
  85. HVAD Waveform Analysis as a Noninvasive Marker of Pulmonary Capillary Wedge Pressure: A First Step Toward the Development of a Smart Left Ventricular Assist Device Pump. ASAIO J. 2018 Jan/Feb; 64(1):10-15.
    View in: PubMed
    Score: 0.077
  86. Adverse Event Rates Change Favorably Over Time for Patients Bridged With the HeartWare Left Ventricular Assist Device. ASAIO J. 2017 Nov-Dec; 63(6):745-751.
    View in: PubMed
    Score: 0.076
  87. Cannula and Pump Positions Are Associated With Left Ventricular Unloading and Clinical Outcome in Patients With HeartWare Left Ventricular Assist Device. J Card Fail. 2018 03; 24(3):159-166.
    View in: PubMed
    Score: 0.076
  88. Decoupling Between Diastolic Pulmonary Artery Pressure and Pulmonary Capillary Wedge Pressure as a Prognostic Factor After Continuous Flow Ventricular Assist Device Implantation. Circ Heart Fail. 2017 Sep; 10(9).
    View in: PubMed
    Score: 0.075
  89. Characterization of Ventricular Tachycardia After Left Ventricular Assist Device Implantation as Destination Therapy: A Single-Center Ablation Experience. JACC Clin Electrophysiol. 2017 12 11; 3(12):1412-1424.
    View in: PubMed
    Score: 0.075
  90. Management of left ventricular assist device infection with heart transplantation. Ann Thorac Surg. 1997 Jul; 64(1):142-7.
    View in: PubMed
    Score: 0.075
  91. Tumor necrosis factor-a levels and non-surgical bleeding in continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2018 01; 37(1):107-115.
    View in: PubMed
    Score: 0.074
  92. The Hemodynamic Effects of Aortic Insufficiency in Patients Supported With Continuous-Flow Left Ventricular Assist Devices. J Card Fail. 2017 Jul; 23(7):545-551.
    View in: PubMed
    Score: 0.074
  93. 3D Morphological Changes in LV and RV During LVAD Ramp Studies. JACC Cardiovasc Imaging. 2018 02; 11(2 Pt 1):159-169.
    View in: PubMed
    Score: 0.073
  94. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure. Circulation. 2017 May 23; 135(21):2003-2012.
    View in: PubMed
    Score: 0.073
  95. Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure. N Engl J Med. 2017 02 02; 376(5):451-460.
    View in: PubMed
    Score: 0.072
  96. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation. Circulation. 1996 Nov 01; 94(9 Suppl):II227-34.
    View in: PubMed
    Score: 0.071
  97. Surgically Corrected Mitral Regurgitation During Left Ventricular Assist Device Implantation Is Associated With Low Recurrence Rate and Improved Midterm Survival. Ann Thorac Surg. 2017 Mar; 103(3):725-733.
    View in: PubMed
    Score: 0.071
  98. Left Ventricular Assist Device Deactivation via Percutaneous Closure of the Outflow Graft. J Card Fail. 2016 Aug; 22(8):653-5.
    View in: PubMed
    Score: 0.069
  99. Screening for Outflow Cannula Malfunction of Left Ventricular Assist Devices (LVADs) With the Use of Doppler Echocardiography: New LVAD-Specific Reference Values for Contemporary Devices. J Card Fail. 2016 Oct; 22(10):808-14.
    View in: PubMed
    Score: 0.069
  100. PCI in Patients Supported With CF-LVADs: Indications, Safety, and Outcomes. J Invasive Cardiol. 2016 Jun; 28(6):238-42.
    View in: PubMed
    Score: 0.069
  101. Hemodynamic Ramp Tests in Patients With Left Ventricular Assist Devices. JACC Heart Fail. 2016 Mar; 4(3):208-17.
    View in: PubMed
    Score: 0.067
  102. Accurate Quantification Methods for Aortic Insufficiency Severity in Patients With LVAD: Role of Diastolic Flow Acceleration and Systolic-to-Diastolic Peak Velocity Ratio of Outflow Cannula. JACC Cardiovasc Imaging. 2016 06; 9(6):641-51.
    View in: PubMed
    Score: 0.067
  103. Predictors of survival following trans-catheter aortic valve closure for left ventricular assist device associated aortic insufficiency. Catheter Cardiovasc Interv. 2016 Apr; 87(5):971-9.
    View in: PubMed
    Score: 0.066
  104. Gastrointestinal bleeding in recipients of the HeartWare Ventricular Assist System. JACC Heart Fail. 2015 Apr; 3(4):303-13.
    View in: PubMed
    Score: 0.064
  105. Can Intraoperative Transesophageal Echocardiography Predict Postoperative Aortic Insufficiency in Patients Receiving Implantable Left Ventricular Assist Devices? J Cardiothorac Vasc Anesth. 2015 Aug; 29(4):901-5.
    View in: PubMed
    Score: 0.063
  106. Modified HeartMate II driveline externalization technique significantly decreases incidence of infection and improves long-term survival. ASAIO J. 2014 Nov-Dec; 60(6):613-6.
    View in: PubMed
    Score: 0.062
  107. Acute kidney injury and mortality following ventricular assist device implantation. Am J Nephrol. 2014; 39(3):195-203.
    View in: PubMed
    Score: 0.059
  108. Percutaneous transcatheter aortic valve closure successfully treats left ventricular assist device-associated aortic insufficiency and improves cardiac hemodynamics. JACC Cardiovasc Interv. 2013 Jan; 6(1):84-9.
    View in: PubMed
    Score: 0.055
  109. Percutaneous transcatheter closure of the aortic valve to treat cardiogenic shock in a left ventricular assist device patient with severe aortic insufficiency. Ann Thorac Surg. 2012 Sep; 94(3):985-8.
    View in: PubMed
    Score: 0.053
  110. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation. 2012 Jun 26; 125(25):3191-200.
    View in: PubMed
    Score: 0.052
  111. Percutaneous transcatheter closure of the native aortic valve to treat de novo aortic insufficiency after implantation of a left ventricular assist device. JACC Cardiovasc Interv. 2012 Mar; 5(3):358-9.
    View in: PubMed
    Score: 0.051
  112. Aortic root and valve thrombosis after implantation of a left ventricular assist device. J Invasive Cardiol. 2011 Apr; 23(4):E63-5.
    View in: PubMed
    Score: 0.048
  113. Regression of cellular hypertrophy after left ventricular assist device support. Circulation. 1998 Aug 18; 98(7):656-62.
    View in: PubMed
    Score: 0.020
  114. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation. 1998 Jun 16; 97(23):2316-22.
    View in: PubMed
    Score: 0.020
  115. Can I Go Home With That Balloon Pump? J Cardiothorac Vasc Anesth. 2018 06; 32(3):1468-1479.
    View in: PubMed
    Score: 0.019
  116. Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy. J Heart Lung Transplant. 1997 Jul; 16(7):765-73.
    View in: PubMed
    Score: 0.019
  117. Elevated Angiopoietin-2 Level in Patients With Continuous-Flow Left Ventricular Assist Devices Leads to Altered Angiogenesis and Is Associated With Higher Nonsurgical Bleeding. Circulation. 2016 Jul 12; 134(2):141-52.
    View in: PubMed
    Score: 0.017
  118. Novel echocardiographic parameters of aortic insufficiency in continuous-flow left ventricular assist devices and clinical outcome. J Heart Lung Transplant. 2016 08; 35(8):976-85.
    View in: PubMed
    Score: 0.017
  119. Intra-aortic balloon pump inserted through the subclavian artery: A minimally invasive approach to mechanical support in the ambulatory end-stage heart failure patient. J Thorac Cardiovasc Surg. 2012 Oct; 144(4):951-5.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.